Construction Spending in

Massachusetts

Massachusetts' biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.

Construction Employment

Union Labor & Earnings, 2012–17

Pharmaceutical & Biotech

9.1

million

Labor Hours Demanded

(14 trades, installation, and maintenance)

2.5

million

Union Labor Hours (est)

(State union% in non-residential = 27.5%)

$30.73

dollars

Average Union Wage

(Union construction workers, 2017 dollars)

$77.2

million

Total Union Earnings (est.)

(Union hours times average wage)

Industry Analysis: Massachusetts

Pharmaceutical Manufacturing (2017)

Firms

96

Firms

Employees

10,072

Employees

Annual Wages

$1.3

billion

Annual Wages

Massachusetts Construction Labor Hours by Trade

Pharmaceutical & Biotech, 2012–17

91,271

Installation

21,479

Maintenance

112,750

Total hours

Largest Construction Projects

Pharmaceutical & Biotech Manufacturing, 2012–17

Vertex Pharmaceuticals Incorporated

Boston Grassroot Fan Pier Biotech R&D Center

Boston, MA

800,000,000

2011-2014

Novartis Institutes for Biomedical Research

Cambridge Vaccine and Diagnostics R&D Center Expansion

Cambridge, MA

600,000,000

2012-2015

Bristol-Myers Squibb Company

Devens Biologics Plant Expansion

Devens, MA

250,000,000

2014-2016

Sanofi Genzyme Corporation

Allston Cell Culture Plant Facilities Equip Upgrade/Renovation ("Project Rena")

Allston, MA

200,000,000

2012-2015

Alnylam Pharmaceuticals Incorporated

Norton Grassroot RNAI-Based Therapeutics Plant

Norton, MA

200,000,000

2016-2018

Pfizer Incorporated

Andover Biotherapeutics, Bulk Pharmaceuticals & APIS Plant Addition

Andover, MA

200,000,000

2016-2019

Biogen Incorporated

Cambridge Grassroot Biotechnology Research Building & Fit Out

Cambridge, MA

150,000,000

2012-2014

MilliporeSigma, a Merck KGaA Company

Burlington Grassroot M-Lab Collaboration Process Solutions R&D Center

Burlington, MA

115,000,000

2016-2017

Moderna Therapeutics Incorporated

Norwood Messenger RNA (MRNA) Therapeutics and Vaccines Plant Addition Fit-Up

Norwood, MA

110,000,000

2016-2018

Shire Human Genetics Therapies-HGT

Lexington Biomfg HGT Project Atlas Campus Expansion Phase II

Lexington, MA

92,000,000

2010-2012

Vertex Pharmaceuticals Incorporated

Boston Grassroot Fan Pier Biotech R&D Center

Boston, MA

Location

800,000,000

Project Value

2011-2014

Years

Take Action

Share the study results and spread the word about the connection between the biopharmaceutical industry and union construction workers in Massachusetts!

You may be surprised by the connection between Massachusetts' biopharmaceutical industry and union labor. A new study finds that from 2012-2017 America’s biopharmaceutical companies invested $4.5 billion in infrastructure in the state, supporting 2.5 million union labor hours. View Massachusetts' labor-industry profile here: https://bit.ly/2EkrSM6

Massachusetts' pharmaceutical companies and the building trades unions have a surprising relationship - a new study finds that from 2012-2017 biopharmaceutical companies invested $4.5 billion in infrastructure in the state, supporting 2.5 million union labor hours. View Massachusetts' labor-industry profile here: https://bit.ly/2EkrSM6

A new study finds that from 2012-2017 Massachusetts' biopharmaceutical companies invested $4.5 billion in infrastructure in the state, supporting 2.5 million union labor hours. Learn more: https://bit.ly/2EkrSM6